However, chemokine CCL20 is upregulated in patients with pancreatic cancer and related to advanced T categories (Rubie et al., 2010), and high expression of CXCL5 is associated with shorter OS in hepatocellular and cholangiocarcinoma (Hu et al., 2018). This evidence concerns the gene CXCL5 and pancreatic neoplasm.